Australia - Medicaments Containing Insulin But Not Antibiotics - Market Analysis, Forecast, Size, Trends And Insights
Report Update: Apr 15, 2024

Australia - Medicaments Containing Insulin But Not Antibiotics - Market Analysis, Forecast, Size, Trends And Insights

Single report
Sent by email within 24h (Mon-Fri)
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Medicaments Containing Insulin Price in Australia - 2023

Contents:

  1. Medicaments Containing Insulin Price in Australia (FOB) - 2022
  2. Medicaments Containing Insulin Price in Australia (CIF) - 2022
  3. Medicaments Containing Insulin Exports in Australia
  4. Medicaments Containing Insulin Imports in Australia

Medicaments Containing Insulin Price in Australia (FOB) - 2022

In 2022, the average medicaments containing insulin export price amounted to $90,820 per ton, waning by -18.4% against the previous year. In general, the export price showed a perceptible contraction. The most prominent rate of growth was recorded in 2020 an increase of 33% against the previous year. As a result, the export price reached the peak level of $146,104 per ton. From 2021 to 2022, the average export prices remained at a lower figure.

There were significant differences in the average prices for the major external markets. In 2022, amid the top suppliers, the country with the highest price was Tonga ($557,901 per ton), while the average price for exports to Malaysia ($71,553 per ton) was amongst the lowest.

From 2014 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Tonga (+37.9%), while the prices for the other major destinations experienced mixed trend patterns.

Medicaments Containing Insulin Price in Australia (CIF) - 2022

In 2022, the average medicaments containing insulin import price amounted to $164,463 per ton, stabilizing at the previous year. In general, the import price posted a prominent increase. The pace of growth appeared the most rapid in 2021 when the average import price increased by 71% against the previous year. The import price peaked in 2022 and is expected to retain growth in the immediate term.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was India ($1,634,128 per ton), while the price for the United States amounted to $22,754 per ton.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by India (+48.7%).

Medicaments Containing Insulin Exports in Australia

In 2022, approx. 1.1 tons of medicaments containing insulin but not antibiotics were exported from Australia; reducing by -57.9% compared with the previous year's figure. Overall, exports, however, saw tangible growth. The growth pace was the most rapid in 2021 with an increase of 188% against the previous year. As a result, the exports reached the peak of 2.5 tons, and then dropped notably in the following year.

In value terms, medicaments containing insulin exports declined rapidly to $96K in 2022. Over the period under review, exports saw a pronounced setback. The pace of growth appeared the most rapid in 2021 with an increase of 120% against the previous year. As a result, the exports reached the peak of $281K, and then dropped remarkably in the following year.

Export of Medicaments Containing Insulin in Australia (Thousand USD)
COUNTRY2019202020212022CAGR,
2019-2022
Malaysia91.210620570.9-8.1%
Tonga0.83.434.211.5143.1%
Samoa1.04.216.05.475.4%
Others16.913.724.98.7-19.9%
Total11012828196.5-4.3%

Top Export Markets for Medicaments Containing Insulin from Australia in 2022:

  1. Malaysia (991.0 kg)
  2. Tonga (21.0 kg)
  3. Samoa (20.0 kg)

Medicaments Containing Insulin Imports in Australia

In 2022, overseas purchases of medicaments containing insulin but not antibiotics decreased by -30.9% to 683 kg for the first time since 2018, thus ending a three-year rising trend. In general, total imports indicated tangible growth from 2019 to 2022: its volume increased at an average annual rate of +2.5% over the last three years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, imports increased by +7.7% against 2019 indices. The most prominent rate of growth was recorded in 2021 with an increase of 49%. As a result, imports attained the peak of 989 kg, and then declined significantly in the following year.

In value terms, medicaments containing insulin imports fell rapidly to $112K in 2022. Over the period under review, imports, however, showed a significant increase. The most prominent rate of growth was recorded in 2021 with an increase of 154% against the previous year. As a result, imports reached the peak of $161K, and then shrank notably in the following year.

Import of Medicaments Containing Insulin in Australia (Thousand USD)
COUNTRY2019202020212022CAGR,
2019-2022
India26.532.011477.943.3%
United States15.715.921.714.3-3.1%
Others12.915.625.520.216.1%
Total55.163.516111226.7%

Top Suppliers of Medicaments Containing Insulin to Australia in 2022:

  1. United States (630.0 kg)
  2. India (48.0 kg)

Source: IndexBox Market Intelligence Platform

This report provides an in-depth analysis of the medicaments containing insulin market in Australia. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale

Country coverage:

  • Australia

Data coverage:

  • Market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Trade (exports and imports) in Australia
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS
  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and Its Prospects

    1. MARKET SIZE
    2. MARKET STRUCTURE
    3. TRADE BALANCE
    4. PER CAPITA CONSUMPTION
    5. MARKET FORECAST TO 2030
  4. 4. MOST PROMISING PRODUCT

    Finding New Products to Diversify Your Business

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCT
    4. MOST TRADED PRODUCT
    5. MOST PROFITABLE PRODUCT FOR EXPORT
  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES
  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Exports

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS
  7. 7. PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE
  8. 8. IMPORTS

    The Largest Import Supplying Countries

    1. IMPORTS FROM 2012–2023
    2. IMPORTS BY COUNTRY
    3. IMPORT PRICES BY COUNTRY
  9. 9. EXPORTS

    The Largest Destinations for Exports

    1. EXPORTS FROM 2012–2023
    2. EXPORTS BY COUNTRY
    3. EXPORT PRICES BY COUNTRY
  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
  11. LIST OF TABLES

    1. Key Findings In 2023
    2. Market Volume, In Physical Terms, 2012–2023
    3. Market Value, 2012–2023
    4. Per Capita Consumption In 2012-2023
    5. Imports, In Physical Terms, By Country, 2012–2023
    6. Imports, In Value Terms, By Country, 2012–2023
    7. Import Prices, By Country Of Origin, 2012–2023
    8. Exports, In Physical Terms, By Country, 2012–2023
    9. Exports, In Value Terms, By Country, 2012–2023
    10. Export Prices, By Country Of Destination, 2012–2023
  12. LIST OF FIGURES

    1. Market Volume, In Physical Terms, 2012–2023
    2. Market Value, 2012–2023
    3. Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
    4. Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
    5. Trade Balance, In Physical Terms, 2012-2023
    6. Trade Balance, In Value Terms, 2012-2023
    7. Per Capita Consumption, 2012-2023
    8. Market Volume Forecast to 2030
    9. Market Value Forecast to 2030
    10. Products: Market Size And Growth, By Type
    11. Products: Average Per Capita Consumption, By Type
    12. Products: Exports And Growth, By Type
    13. Products: Export Prices And Growth, By Type
    14. Production Volume And Growth
    15. Exports And Growth
    16. Export Prices And Growth
    17. Market Size And Growth
    18. Per Capita Consumption
    19. Imports And Growth
    20. Import Prices
    21. Production, In Physical Terms, 2012–2023
    22. Production, In Value Terms, 2012–2023
    23. Imports, In Physical Terms, 2012–2023
    24. Imports, In Value Terms, 2012–2023
    25. Imports, In Physical Terms, By Country, 2023
    26. Imports, In Physical Terms, By Country, 2012–2023
    27. Imports, In Value Terms, By Country, 2012–2023
    28. Import Prices, By Country Of Origin, 2012–2023
    29. Exports, In Physical Terms, 2012–2023
    30. Exports, In Value Terms, 2012–2023
    31. Exports, In Physical Terms, By Country, 2023
    32. Exports, In Physical Terms, By Country, 2012–2023
    33. Exports, In Value Terms, By Country, 2012–2023
    34. Export Prices, By Country Of Destination, 2012–2023
Store
Blog
Event
Australia - Medicaments Containing Insulin But Not Antibiotics - Market Analysis, Forecast, Size, Trends And Insights
$599
Apr 15, 2024
Eye 422

This report provides an in-depth analysis of the medicaments containing insulin market in Australia.

Australia - Medicaments Containing Hormones But Not Antibiotics - Market Analysis, Forecast, Size, Trends And Insights
$599
Apr 6, 2024
Eye 341

This report provides an in-depth analysis of the medicaments containing hormones market in Australia.

Australia - Medicaments Containing Penicillins Or Derivatives Thereof - Market Analysis, Forecast, Size, Trends And Insights
$599
Apr 1, 2024
Eye 381

This report provides an in-depth analysis of the medicaments containing penicillin market in Australia.

Australia - Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses - Market Analysis, Forecast, Size, Trends And Insights
$599
Apr 13, 2024
Eye 191

This report provides an in-depth analysis of the market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses in Australia.

Australia - Medicaments Of Alkaloids Or Derivatives Thereof - Market Analysis, Forecast, Size, Trends And Insights
$599
Apr 1, 2024
Eye 224

This report provides an in-depth analysis of the market for medicaments of alkaloids or derivatives thereof in Australia.

Australia - Medicaments Of Other Antibiotics - Market Analysis, Forecast, Size, Trends And Insights
$599
Apr 1, 2024
Eye 218

This report provides an in-depth analysis of the market for medicaments of other antibiotics in Australia.

World - Medicaments Containing Insulin But Not Antibiotics - Market Analysis, Forecast, Size, Trends And Insights
$599
Apr 15, 2024
Eye 476

This report provides an in-depth analysis of the global medicaments containing insulin market.

World - Medicaments Containing Hormones But Not Antibiotics - Market Analysis, Forecast, Size, Trends And Insights
$599
Apr 6, 2024
Eye 479

This report provides an in-depth analysis of the global medicaments containing hormones market.

World - Medicaments Containing Penicillins Or Derivatives Thereof - Market Analysis, Forecast, Size, Trends And Insights
$599
Apr 1, 2024
Eye 567

This report provides an in-depth analysis of the global medicaments containing penicillin market.

World - Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses - Market Analysis, Forecast, Size, Trends And Insights
$599
Apr 13, 2024
Eye 305

This report provides an in-depth analysis of the global market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses.

Free Data: Medicaments Containing Insulin But Not Antibiotics - Australia